Total Payments
$4,325
2024 Payments
$144.85
Companies
19
Transactions
109
Medicare Patients
1,606
Medicare Billing
$156,133
Payment Breakdown by Category
Food & Beverage$3,460 (80.0%)
Travel$852.76 (19.7%)
Education$12.70 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,460 | 102 | 80.0% |
| Travel and Lodging | $852.76 | 6 | 19.7% |
| Education | $12.70 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,636 | 16 | $0 (2019) |
| ABIOMED | $729.68 | 6 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $344.86 | 28 | $0 (2019) |
| Medtronic Vascular, Inc. | $317.57 | 4 | $0 (2020) |
| Abbott Laboratories | $289.81 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $281.30 | 21 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $243.69 | 18 | $0 (2020) |
| Penumbra, Inc. | $152.72 | 1 | $0 (2023) |
| Pulmonx Corporation | $125.00 | 1 | $0 (2022) |
| LivaNova USA, Inc. | $35.46 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $144.85 | 1 | ABIOMED ($144.85) |
| 2023 | $292.50 | 2 | Penumbra, Inc. ($152.72) |
| 2022 | $421.75 | 3 | Abbott Laboratories ($150.03) |
| 2020 | $482.63 | 17 | ABIOMED ($189.61) |
| 2019 | $786.82 | 27 | Medtronic Vascular, Inc. ($194.30) |
| 2018 | $1,688 | 37 | Edwards Lifesciences Corporation ($1,372) |
| 2017 | $508.19 | 22 | ABIOMED ($123.70) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $144.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/27/2023 | Abbott Laboratories | 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) | Food and Beverage | In-kind items and services | $139.78 | General |
| Category: Heart Failure | ||||||
| 02/15/2023 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $152.72 | General |
| Category: Peripheral Intervention | ||||||
| 09/28/2022 | Abbott Laboratories | 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) | Food and Beverage | In-kind items and services | $150.03 | General |
| Category: Heart Failure | ||||||
| 09/15/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $146.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/17/2022 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PULMONOLOGY | ||||||
| 10/14/2020 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $147.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2020 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $41.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Cardiology | ||||||
| 08/06/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiology | ||||||
| 07/10/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Cardiology | ||||||
| 06/05/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiology | ||||||
| 05/08/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Cardiology | ||||||
| 04/22/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Cardiology | ||||||
| 03/02/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiology | ||||||
| 02/06/2020 | Medtronic Vascular, Inc. | HeartWare HVAD (Device) | Food and Beverage | In-kind items and services | $123.27 | General |
| Category: Ventricular Assist Devices | ||||||
| 01/30/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardiology | ||||||
| 01/28/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: Cardiology | ||||||
| 01/23/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: Cardiology | ||||||
| 01/13/2020 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $11.86 | General |
| Category: Dental and Oral Health | ||||||
| 01/07/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: Cardiology | ||||||
| 01/06/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: Cardiology | ||||||
| 01/06/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: Cardiology | ||||||
| 12/20/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiology | ||||||
| 12/06/2019 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 220 | 336 | $121,156 | $32,140 |
| 2022 | 10 | 275 | 361 | $100,029 | $24,636 |
| 2021 | 13 | 494 | 631 | $167,725 | $43,754 |
| 2020 | 13 | 617 | 813 | $218,300 | $55,603 |
Total Patients
1,606
Total Services
2,141
Medicare Billing
$156,133
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 48 | 87 | $58,551 | $14,724 | 25.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 73 | 143 | $45,331 | $13,307 | 29.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 30 | $6,630 | $1,896 | 28.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $8,624 | $1,801 | 20.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 18 | 18 | $684.00 | $132.86 | 19.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 19 | 19 | $532.00 | $119.00 | 22.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 11 | 11 | $440.00 | $89.32 | 20.3% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 14 | 14 | $364.00 | $71.39 | 19.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 39 | 83 | $55,859 | $13,862 | 24.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 57 | $18,069 | $4,493 | 24.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 13 | 24 | $8,088 | $2,095 | 25.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 29 | $6,409 | $1,668 | 26.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 16 | 17 | $5,610 | $1,191 | 21.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 44 | 44 | $1,672 | $382.32 | 22.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 12 | $1,428 | $334.23 | 23.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 44 | 44 | $1,232 | $287.81 | 23.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 24 | 24 | $960.00 | $173.40 | 18.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 27 | 27 | $702.00 | $149.81 | 21.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 72 | 165 | $52,088 | $13,526 | 26.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 53 | 75 | $49,926 | $12,894 | 25.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 42 | 42 | $25,756 | $6,622 | 25.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 31 | 37 | $12,210 | $3,969 | 32.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 38 | 43 | $9,388 | $2,173 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 15 | $4,935 | $1,500 | 30.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $2,453 | $831.27 | 33.9% |
About Dr. Jordan Weingarten, M.D
Dr. Jordan Weingarten, M.D is a Pulmonary Disease healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639194939.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jordan Weingarten, M.D has received a total of $4,325 in payments from pharmaceutical and medical device companies, with $144.85 received in 2024. These payments were reported across 109 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,460).
As a Medicare-enrolled provider, Weingarten has provided services to 1,606 Medicare beneficiaries, totaling 2,141 services with total Medicare billing of $156,133. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Austin, TX
- Active Since 07/13/2006
- Last Updated 05/12/2016
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1639194939
Products in Payments
- Impella (Device) $729.68
- EV1000 Clinical Platform (Device) $510.46
- 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) $289.81
- UPTRAVI (Drug) $243.69
- ANORO (Drug) $196.13
- Indigo System (Device) $152.72
- Crescent Catheter (Device) $149.11
- LONHALA MAGNAIR (Drug) $130.27
- FloTrac Sensor (Device) $129.37
- CHARTIS CATHETER (Device) $125.00
- HeartWare HVAD (Device) $123.27
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $117.95
- BROVANA (Drug) $105.14
- Utibron (Drug) $69.19
- NUCALA (Biological) $58.23
- UTIBRON (Drug) $40.26
- Protek Duo (Device) $35.46
- BREO (Drug) $26.94
- CARDIOHELP (Device) $21.30
- HemoSphere advanced monitoring platform (Device) $20.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Austin
Dr. William Bartek, M.d, M.D
Pulmonary Disease — Payments: $277,754
Pulmonary Disease $277,754
John Hinze, D.o, D.O
Pulmonary Disease — Payments: $63,477
Pulmonary Disease $63,477
Dr. Mehdi Mirsaeidi, M.d, M.D
Pulmonary Disease — Payments: $54,206
Pulmonary Disease $54,206
Dr. Subramaniyam Rajan, M.d, M.D
Pulmonary Disease — Payments: $48,598
Pulmonary Disease $48,598
Edward Ortiz, M.d, M.D
Pulmonary Disease — Payments: $30,048
Pulmonary Disease $30,048
Ernest Lawrence, M.d, M.D
Pulmonary Disease — Payments: $24,422
Pulmonary Disease $24,422